Related Experiment Video
Updated: Jul 9, 2025

Reverse Genetic Approach to Identify Regulators of Pigmentation using Zebrafish
Published on: March 1, 2022
The inhibition of VDAC1 oligomerization promotes pigmentation through the CaMK-CRTCs/CREB-MITF pathway
Jinpeng Lv1, Ximei Zhang2, Xiaohong An3
1School of Pharmacy, Changzhou University, Changzhou, 213000, China; Department of Dermatology, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, Changzhou, 213000, China.
Abstract:
The voltage-dependent anion channel 1 (VDAC1) forms an oligomeric structure on the mitochondrial outer membrane, which plays critical roles in many physiological processes. Research studies have demonstrated that the knockout of VDAC1 increases pigment content and up-regulates the expression of melanogenic genes. Due to its involvement in various physiological processes, the depletion of VDAC1 has significant detrimental effects on cellular functions and the inhibition of VDAC1 oligomerization has recently emerged as a promising strategy for the treatment of several diseases. In this study, we found that VDAC1 oligomerization inhibitors, VBIT-12 and NSC-15364, promote melanogenesis, dendrite formation and melanosome transport in human epidermal melanocytes (HEMCs). Mechanistically, treatment of HEMCs with an oligomerization inhibitor increased the level of cytoplasmic calcium ions, which activated calcium-calmodulin dependent protein kinase (CaMK) and led to the phosphorylation of CREB and the nuclear translocation of CREB-regulated transcription coactivators (CRTCs). Subsequently, CRTCs, p-CREB and CREB-binding protein (CBP) in the nucleus cooperatively recruit the transcription machinery to initiate the transcription of MITF thus promoting pigmentation. Importantly, our study also demonstrates that VDAC1 oligomerization inhibitors increase pigmentation in zebrafish and in human skin explants, highlighting their potential as a therapeutic strategy for skin pigmentation disorders.
Insights
Voltage-dependent anion channel 1 (VDAC1) inhibitors promote skin pigmentation by enhancing melanogenesis and melanosome transport. These compounds show potential for treating pigmentation disorders.
Area of Science:
- Mitochondrial biology
- Cellular physiology
- Dermatology
Background:
- Voltage-dependent anion channel 1 (VDAC1) is crucial for cellular functions and its knockout increases pigment content.
- Inhibiting VDAC1 oligomerization is a potential therapeutic strategy for various diseases.
Purpose of the Study:
- To investigate the effect of VDAC1 oligomerization inhibitors on melanogenesis in human epidermal melanocytes (HEMCs).
- To elucidate the molecular mechanisms underlying VDAC1 inhibitor-induced pigmentation.
- To evaluate the in vivo efficacy of VDAC1 inhibitors in promoting skin pigmentation.
Main Methods:
- Treatment of HEMCs with VDAC1 oligomerization inhibitors (VBIT-12, NSC-15364).
- Analysis of melanogenesis, dendrite formation, and melanosome transport.
- Investigation of intracellular signaling pathways involving calcium ions, CaMK, CREB, CRTCs, and MITF.
- In vivo studies in zebrafish and human skin explants.
Main Results:
- VDAC1 inhibitors promoted melanogenesis, dendrite formation, and melanosome transport in HEMCs.
- Inhibitors increased intracellular calcium, activated CaMK, leading to CREB phosphorylation and CRTC nuclear translocation.
- This cascade resulted in increased MITF transcription and subsequent pigmentation.
- In vivo studies confirmed increased pigmentation in zebrafish and human skin explants.
Conclusions:
- VDAC1 oligomerization inhibitors effectively promote skin pigmentation through a calcium-dependent signaling pathway.
- These findings highlight the therapeutic potential of VDAC1 inhibitors for treating skin pigmentation disorders.
Related Concept Videos
MAPK Signaling Cascades
Photoreceptors and Visual Pathways
Inhibition of Cdk Activity
Regulation of Angiogenesis and Blood Supply

